EMILY CAPLAN: Open Payments
NPI 1093569378 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Novo Nordisk Inc | 3 | $57 |
| Lilly USA, LLC | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Exact Sciences Corporation | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: MOUNJARO, AIRSUPRA, REPATHA, Wegovy, GARDASIL 9, The Cologuard Plus Collection Kit, GEMTESA, Ozempic.
Industry payments across VA — which companies pay providers there.
